Withdrawal of acne drug could lead to more settlements
By Nora Lockwood Tooher
Staff writer
Published: July 6, 2009
Tags: Accutane, product liability
Roche Holding's decision to withdraw its acne drug Accutane from the U.S. market may help fuel settlement of the costly mass tort litigation proceeding against the company.
Roche, which is based in Switzerland, faces about 700 personal injury suits from plaintiffs who claim they developed inflammatory bowel disease because of Accutane.
Most of the suits have been ...
© Copyright 2010 Lawyers USA. All Rights Reserved.
Login required
© Copyright 2010 Lawyers USA. All Rights Reserved.
FREE White Papers
Most Viewed Stories
Stay Connected with Lawyers USA
Lawyers USA keeps you connected with all the latest news affecting you and your practice with Daily, Practice and Breaking News alerts.
To Sign-up or Manage your Alerts, click here.
Feeds/Web 2.0:
LEGAL BLOGS
DC Dicta Legal buzz from Washington
FEATURED PODCAST
Tech toys for the holidays
Jim Calloway, the Director of the Oklahoma Bar Association Management Assistance Program, and Sharon Nelson, president of Sensei Enterprises, Inc. present a series of great gift ideas for the tech-savvy professional on your holiday shopping list.
Click here to listen to the podcast.
Click here for the Podcast archive.
Comments